Education
About Us
Working with TipRanks
Follow Us
Rainmed Medical Limited (HK:2297)
:2297
2297 Stock Chart & Stats
HK$0.26
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.26
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.13 - HK$0.53
Previous CloseN/A
Volume40.00K
Average Volume (3M)3.71M
Market Cap
HK$406.39M
Enterprise ValueHK$339.79M
Total Cash (Recent Filing)HK$200.75M
Total Debt (Recent Filing)HK$33.80M
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding1,401,358,800
10 Day Avg. Volume1,490,900
30 Day Avg. Volume3,709,666
Financial Highlights & Ratios
PEG Ratio-1.99
Price to Book (P/B)0.45
Price to Sales (P/S)4.58
P/FCF Ratio-1.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Equity PositionA strong equity position indicates financial stability and low financial risk, providing a solid foundation for potential future growth and investment.
Low LeverageLow leverage reduces financial risk and interest burden, allowing the company more flexibility to invest in growth opportunities without the pressure of high debt repayments.
Innovative Product PortfolioAn innovative product portfolio in medical technology positions the company well to capture market share in a growing industry focused on improving healthcare efficiencies and outcomes.
Bears Say
Declining RevenuesDeclining revenues indicate challenges in market demand or competitive positioning, which can impact long-term profitability and growth potential.
Negative Cash FlowsNegative cash flows highlight difficulties in generating cash from operations, which can constrain the company's ability to invest in growth or manage financial obligations.
Operational InefficienciesNegative EBIT and EBITDA margins suggest operational inefficiencies, which can hinder profitability and require strategic adjustments to improve cost management and operational effectiveness.
Rainmed Medical Limited News
2297 FAQ
What was Rainmed Medical Limited’s price range in the past 12 months?
Rainmed Medical Limited lowest stock price was HK$0.13 and its highest was HK$0.53 in the past 12 months.
What is Rainmed Medical Limited’s market cap?
Rainmed Medical Limited’s market cap is HK$406.39M.
When is Rainmed Medical Limited’s upcoming earnings report date?
Rainmed Medical Limited’s upcoming earnings report date is Mar 26, 2026 which is in 31 days.
How were Rainmed Medical Limited’s earnings last quarter?
Rainmed Medical Limited released its earnings results on Aug 28, 2025. The company reported -HK$0.029 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.029.
Is Rainmed Medical Limited overvalued?
According to Wall Street analysts Rainmed Medical Limited’s price is currently Overvalued.
Does Rainmed Medical Limited pay dividends?
Rainmed Medical Limited does not currently pay dividends.
What is Rainmed Medical Limited’s EPS estimate?
Rainmed Medical Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rainmed Medical Limited have?
Rainmed Medical Limited has 1,401,358,800 shares outstanding.
What happened to Rainmed Medical Limited’s price movement after its last earnings report?
Rainmed Medical Limited reported an EPS of -HK$0.029 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Rainmed Medical Limited?
Currently, no hedge funds are holding shares in HK:2297
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Rainmed Medical Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
78.12%
12-Months-Change
Fundamentals
Return on Equity
-23.53%
Trailing 12-Months
Asset Growth
-14.43%
Trailing 12-Months
Company Description
Rainmed Medical Limited
Rainmed Medical Limited, a medical device company, focus on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microvascular resistance systems. The company offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system, which calculates FFR values based on a three-dimensional model of the coronary arterial system restored from two angiograms and FlashAngio caIMR System, a non-invasive microcirculatory lesion diagnosis and treatment system. It is also involved in developing intelligent angiographic injection, flash robot vascular intervention navigation operation system, and flash renal denervation systems. The company was founded in 2014 and is headquartered in Suzhou, China.
Technical Analysis
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
―
MicroPort CardioFlow Medtech Corp.
―
Broncus Holding Corp.
―
Venus Medtech (Hangzhou), Inc. Class H
―
Shanghai Heartcare Medical Technology Corp. Ltd. Class H
―